Evidence map›Paper›PMID 26497493›Full record

Trial reportGenome medicine2015

Dynamic tracking of functional gene modules in treated juvenile idiopathic arthritis.

Nan Du, Kaiyu Jiang, Ashley D Sawle, Mark Barton Frank, Carol A Wallace, Aidong Zhang, James N Jarvis

Abstract readClinical Trial
In one paragraph

Trial report in Genome medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Immunomics in Pediatric Rheumatic Diseases.Frontiers in medicine · 2019
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nan DuDepartment of Computer Sciences and Engineering, University at Buffalo, Buffalo, NY, USA. nandu2048@gmail.com.
Kaiyu JiangDepartment of Pediatrics, Rheumatology Research, University at Buffalo School of Medicine, Buffalo, NY, USA. kaiyujia@buffalo.edu.
Ashley D SawleThe Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, 10032, USA. ads2202@columbia.edu.
Mark Barton FrankOklahoma Medical Research Foundation, Clinical Immunology Program, Oklahoma City, OK, USA. bart-frank@omrf.org.
Carol A WallaceDepartment of Pediatrics, University of Washington, Seattle, WA, USA. cwallace@u.washington.edu.
Aidong ZhangDepartment of Computer Sciences and Engineering, University at Buffalo, Buffalo, NY, USA. azhang@buffalo.edu.
James N JarvisDepartment of Pediatrics, Rheumatology Research, University at Buffalo School of Medicine, Buffalo, NY, USA. jamesjar@buffalo.edu.

Funding

Early Aggressive Therapy in Juvenile Idiopathic ArthritisR01AR049762 · NIAMS · SEATTLE CHILDREN'S HOSPITAL · PI WALLACE, CAROL A · 2006 to 2009
$4.1M
Microarray-Based Biomarkers in Juvenile Idiopathic ArthritisR01AR060604 · NIAMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI JARVIS, JAMES N · 2011 to 2015
$2.6M
Dynamics of Therapeutic Response Within the TREAT TrialR01AI084200 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI JARVIS, JAMES N · 2009 to 2010
$1.0M
NIAID NIH HHS R01 AI-084200NIAID NIH HHS R01 AI084200NIAMS NIH HHS R01 AR049762NIAMS NIH HHS R01-AR 049762NIAMS NIH HHS R01 AR-060604NIAMS NIH HHS R01 AR060604
6 · The paper itself

Abstract

backgroundWe have previously shown that childhood-onset rheumatic diseases show aberrant patterns of gene expression that reflect pathology-associated co-expression networks. In this study, we used novel computational approaches to examine how disease-associated networks are altered in one of the most common rheumatic diseases of childhood, juvenile idiopathic arthritis (JIA).

methodsUsing whole blood gene expression profiles derived from children in a pediatric rheumatology clinical trial, we used a network approach to understanding the impact of therapy and the underlying biology of response/non-response to therapy.

resultsWe demonstrate that therapy for JIA is associated with extensive re-ordering of gene expression networks, even in children who respond inadequately to therapy. Furthermore, we observe distinct differences in the evolution of specific network properties when we compare children who have been treated successfully with those who have inadequate treatment response.

conclusionsDespite the inherent noisiness of whole blood gene expression data, our findings demonstrate how therapeutic response might be mapped and understood in pathologically informative cells in a broad range of human inflammatory diseases.

Indexed as

AdolescentAntirheumatic AgentsArthritis, JuvenileChildChild, PreschoolDrug ResistanceEtanerceptFemaleHumansMaleMethotrexatePrednisoneSequence Analysis, RNATranscriptomeAntirheumatic AgentsEtanerceptMethotrexatePrednisone

Identifiers

PMID26497493
PMCPMC4619406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.